EN DE
Watch ACUTAAS CHEMICALS LTD for free: we tell you when fair value or trend changes.
Data-driven stock valuation

ACUTAAS CHEMICALS LTD (ACUTAAS) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of ACUTAAS CHEMICALS LTD stock ₹610, price ₹4,039, that is 84.9% below the price, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE00FF01025

AC ACUTAAS CHEMICALS LTD logo Thin data Nov 16, 2026

ACUTAAS CHEMICALS LTD

ACUTAAS · NSE

Far too expensive (fair value 85% below the price), but solid company and rising price: meets 2 of 3 rules.

Get notified free when this changes
Quality 60/100 
Rising price (uptrend) 
Highly profitable · 27.9% net margin (TTM) 
Low debt 
Last quarter vs. a year ago: revenue +44%, profit +73%. 
Expensive Growth (revenue 5y +31.5 %/yr in INR) 
0.1% dividend yield · Token dividend
Mixed vs. peers (7/13) 
Wide moat 89/100 · thin data
Fair value ₹609.89 · Strongly overvalued 
Negative free cash flow 
Thin data 
Extreme value⟳ Cyclical
Watch ACUTAAS CHEMICALS LTD for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹4,039 ₹399.70 Fair Value ₹609.89 Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range ₹399.70 – ₹4,039 · fair‑value band ₹463.19 – ₹756.58 · the ₹4,039 price screens above the ₹609.89 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow ACUTAAS CHEMICALS in your weekly email

Every Wednesday you see whether ACUTAAS CHEMICALS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Show moreShow less

The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications.

It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals.

The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

Stock analysis

ACUTAAS CHEMICALS LTD (ACUTAAS) currently trades at ₹4,039, while our model-based Fair Value estimate is ₹609.89, 85% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹1,486 per share, and 0 of the 16 models we run sit above the ₹4,039 price.

Bear case: the Asset-Based group reads lowest at ₹67.28, and 16 of the 16 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹463.19 (bear) to ₹756.58 (bull), the price of ₹4,039 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

ACUTAAS CHEMICALS LTD reported revenue of ₹13.4B in FY2026 versus ₹5.2B in FY2022, a compound +26.7%/yr. Reported net income was ₹3.6B in FY2026, compounding +49.2%/yr from FY2022.

Key figures

Market cap ₹332B (≈ $3.5B) Mid · P/E ratio 75.6 · P/S ratio 21.1 · EPS (TTM) ₹53.42 · Dividend yield 0.1% · Net margin 27.9% · Return on equity 26.1% · Return on assets (EBIT) 15.0% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 89 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and 152% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −48% fair-value upside, at −85%, ACUTAAS screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (₹19.48 to ₹2,064). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ₹463.19 Fair Value ₹609.89 Bull ₹756.58
Price ₹4,039 · Downside -84.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹32.09 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV ₹342.02 ₹385.51 ₹421.86 74
ROIC Compounder ₹429.81 ₹621.65 ₹728.83 72
Residual Income ₹247.70 ₹366.67 ₹723.93 71
All 16 models by family
Earnings-Based
Graham-Dodd ₹295.90 ₹2,064 ₹2,896 63
Lynch FV ₹912.73 ₹1,304 ₹1,695 61
PEG = 1.0 ₹912.73 ₹1,304 ₹1,695 57
EPV ₹342.02 ₹385.51 ₹421.86 74
Dividend Discount
Gordon GGM ₹11.79 ₹21.43 ₹29.72 68
DDM Multi-Stage ₹11.79 ₹19.48 ₹22.87 67
Multiples
P/E Multiple ₹554.81 ₹739.74 ₹924.68 63
P/S Multiple ₹184.04 ₹245.39 ₹306.74 58
P/B Multiple ₹423.78 ₹565.04 ₹706.31 55
EV/EBIT ₹593.07 ₹783.05 ₹973.04 66
EV/EBITDA ₹463.19 ₹609.89 ₹756.58 67
EV/Revenue ₹194.89 ₹268.51 ₹342.12 54
Asset-Based
NCAV (Graham) ₹44.41 ₹67.28 ₹84.11 54
Economic Profit
Residual Income ₹247.70 ₹366.67 ₹723.93 71
ROIC Compounder ₹429.81 ₹621.65 ₹728.83 72
Growth Earnings
Growth-Adj P/E ₹1,040 ₹1,486 ₹1,931 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 76
How much profit the company makes from its sales and capital
Quality Growth 93
Are margins and returns getting better?
Cashflow 28
Do the profits arrive as real cash?
Financial strength 87
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 65
How calm the share price moves, does not count
Price momentum 90
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 100
Distance to the 52-week high, does not count
New shares 48
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+33.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.5%
Start year 2021 (pandemic). Over 10 years: +24.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.0%
What shareholders gained per year (last 5 years), in INR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+22.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+22.4%
Dividend (yield on the price)0.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.34.4% vs 27.8%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 33%
2026 sits 280% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2021 (pandemic)

ACUTAAS screens overvalued: fair value 85% below the price. Compare with Linde plc →

Compare ACUTAAS CHEMICALS LTD with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 755 stocks

Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 60 · Above median
Fair Value upside −84.9% · Bottom 25%
Profitability
Return on equity (12 months) 26.1% · Top 25%
Return on assets 18.0% · Top 25%
Net margin (12 months) 27.9% · Top 25%
Operating margin (12 months) 38.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 44.4% · Top 25%
Dividend yield (12 months) 0.1% · Bottom 25%

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 75.6× · Priciest 25%
P/B 20.06× · Priciest 25%
P/S (12 months) 21.08× · Priciest 25%
EV/EBITDA 54.6× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 4
FUTURE (revenue growth)100 · sector 67
PAST (return on equity)100 · sector 25
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)1 · sector 30

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥68.09 ¥68.03 +0% vs ACUTAAS
Linde plc LIN $526.06 $446.62 −15% vs ACUTAAS
PPG Industries, Inc PPG $122.56 $77.68 −37% vs ACUTAAS
DSM-Firmenich AG DSFIR CHF 97.75 CHF 58.34 −40% vs ACUTAAS
Sika AG SIKA CHF 191.95 CHF 98.89 −48% vs ACUTAAS
The Sherwin-Williams Company SHW $349.89 $152.59 −56% vs ACUTAAS
Givaudan SA GIVN CHF 4,090 CHF 1,629 −60% vs ACUTAAS
EMS-CHEMIE HOLDING AG EMSN CHF 846.50 CHF 284.63 −66% vs ACUTAAS
Ecolab Inc ECL $309.27 $97.18 −69% vs ACUTAAS
Air Products and Chemicals, Inc APD $316.53 $75.33 −76% vs ACUTAAS

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ACUTAAS CHEMICALS LTD: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "ACUTAAS CHEMICALS LTD Fair Value". https://www.fairvalue-calculator.com/stock/ACUTAAS

Frequently asked questions

Is ACUTAAS CHEMICALS LTD (ACUTAAS) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of ₹609.89 versus a price of ₹4,039, about 85% lower (overvalued).
What is the fair value of ACUTAAS?
Our model-based fair value for ACUTAAS CHEMICALS LTD is ₹609.89 (as of Nov 16, 2026), built from audited fundamentals. The current price: ₹4,039.
What is the quality score of ACUTAAS?
ACUTAAS CHEMICALS LTD has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ACUTAAS CHEMICALS LTD (ACUTAAS)?
Our model-based price target is the fair value of ₹609.89 (as of Nov 16, 2026) from 16 valuation models. Cautious scenario ₹463.19, optimistic scenario ₹756.58. It is a calculation from audited fundamentals, not an analyst target.
What is the ACUTAAS CHEMICALS LTD stock forecast for 2026?
Our models put fair value at ₹609.89, about 85% lower versus a price of ₹4,039 (overvalued). Cautious scenario ₹463.19, optimistic scenario ₹756.58. The calculation is refreshed regularly with new filings.
What is the revenue of ACUTAAS CHEMICALS LTD (ACUTAAS)?
ACUTAAS CHEMICALS LTD reported trailing-twelve-month revenue of about ₹15.7B (latest available figure, as of Nov 16, 2026).
Does ACUTAAS CHEMICALS LTD pay a dividend?
ACUTAAS CHEMICALS LTD currently shows a dividend yield of 0.06% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of ACUTAAS CHEMICALS LTD (ACUTAAS) and when is the ex-dividend date?
ACUTAAS CHEMICALS LTD pays a dividend of ₹2.50 per share a year, a dividend yield of 0.1%. The last ex-dividend date was Sep 17, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 4.7% of earnings. Our assessment: Token dividend. At a yield of 0.1% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.1% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of ACUTAAS CHEMICALS LTD (ACUTAAS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ACUTAAS CHEMICALS LTD it is ₹609.89 per share (as of Nov 16, 2026), against a price of ₹4,039. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is ACUTAAS CHEMICALS LTD stock overvalued or undervalued in 2026?
As of Nov 16, 2026, ACUTAAS trades above its calculated fair value: price ₹4,039, fair value ₹609.89, a gap of about −85% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ACUTAAS?
No. The price is what the market pays today (₹4,039); the fair value is what the company's own numbers justify (₹609.89). For ACUTAAS CHEMICALS LTD the two are ₹3,429 per share apart. That gap is exactly why we show both numbers side by side.
How much is ACUTAAS CHEMICALS LTD worth?
The market values ACUTAAS CHEMICALS LTD at about ₹332B (market capitalisation, as of Nov 16, 2026). Per share that is ₹4,039; our models calculate a fair value of ₹609.89 per share.
What do the bullish and bearish scenarios say about ACUTAAS?
Our models span a range for ACUTAAS CHEMICALS LTD: cautious scenario ₹463.19, base ₹609.89, optimistic ₹756.58 per share (as of Nov 16, 2026, price ₹4,039). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ACUTAAS?
ACUTAAS CHEMICALS LTD trades at a price-to-earnings ratio of 75.6 (as of Nov 16, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹609.89 is built from several models across several years. Other multiples: P/B 20.1, P/S 21.1, EV/EBITDA 54.6.
How solid is the balance sheet of ACUTAAS CHEMICALS LTD (ACUTAAS)?
Balance-sheet figures for ACUTAAS CHEMICALS LTD (as of Nov 16, 2026): return on equity 26.1%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is ACUTAAS from its 52-week high?
ACUTAAS CHEMICALS LTD trades at ₹4,039, at its 52-week high of ₹4,039 and 152% above the low of ₹1,601 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹609.89 is for.
Which stocks are comparable to ACUTAAS CHEMICALS LTD?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ACUTAAS CHEMICALS LTD stock attractive at the current price?
The data as of Nov 16, 2026: price ₹4,039, calculated fair value ₹609.89 (−85%), Quality Score 60/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ACUTAAS calculated?
We run ACUTAAS CHEMICALS LTD through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹609.89 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. ACUTAAS CHEMICALS LTD itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The closing price on Nov 13, 2026 was ₹4,039. Our model-based fair value is ₹609.89, about 85% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ACUTAAS CHEMICALS LTD right now?
The price sits above even our optimistic bull case (₹756.58). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of ACUTAAS CHEMICALS LTD (ACUTAAS) come from?
Earnings per share at ACUTAAS CHEMICALS LTD grew 25.2 % a year from 2015 to 2026. Broken into its drivers: revenue per share +12.4 %, EBIT margin +11.0 %, tax rate +0.7 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of ACUTAAS CHEMICALS LTD

How large is the market capitalisation of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The market capitalisation of ACUTAAS CHEMICALS LTD is ₹332B (≈ $3.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The price-to-sales ratio of ACUTAAS CHEMICALS LTD is 21.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of ACUTAAS CHEMICALS LTD (ACUTAAS)?
Earnings per share at ACUTAAS CHEMICALS LTD are ₹53.42 (price ÷ EPS = P/E 75.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The dividend yield of ACUTAAS CHEMICALS LTD is 0.1% (payout 4.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The net margin of ACUTAAS CHEMICALS LTD is 27.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The return on equity (ROE) of ACUTAAS CHEMICALS LTD is 26.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ACUTAAS CHEMICALS LTD (ACUTAAS)?
On an EBIT basis the return on assets of ACUTAAS CHEMICALS LTD is 15.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ACUTAAS CHEMICALS LTD (ACUTAAS)?
The operating margin of ACUTAAS CHEMICALS LTD is 38.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ACUTAAS CHEMICALS LTD (ACUTAAS)?
Revenue at ACUTAAS CHEMICALS LTD is growing 44.4% versus a year earlier (3y avg +29.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at ACUTAAS CHEMICALS LTD (ACUTAAS)?
Earnings per share at ACUTAAS CHEMICALS LTD are growing 72.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does ACUTAAS CHEMICALS LTD (ACUTAAS) generate?
The free cash flow of ACUTAAS CHEMICALS LTD is −₹285M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does ACUTAAS CHEMICALS LTD (ACUTAAS) hold?
ACUTAAS CHEMICALS LTD holds more cash than debt, ₹1.9B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch ACUTAAS CHEMICALS LTD in the live analysis

One click puts ACUTAAS CHEMICALS LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.